We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Aerobic Bacteria Rapidly Identified by MALDI-TOF Mass Spectrometry

By LabMedica International staff writers
Posted on 27 Jan 2016
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) is a diagnostic tool for the identification of organisms routinely found in the microbiology laboratory. More...


MALDI-TOF MS has been proven to be a rapid and cost-effective diagnostic method for routine use in the clinical microbiology laboratory and MALDI-TOF MS technology uses ionizing laser for structural elements of the isolate to generate isolate-derived spectra, which is then compared to a reference database.

Scientists at the Children's Hospital Los Angeles (CA, USA) and their colleague at the Keck School of Medicine (Los Angeles, CA, USA) used isolates previously recovered by routine culture and workup from clinical specimens were cultured to appropriate media, identified directly by MALDI-TOF MS, and compared to results from various biochemical identification methods. A total of 996 aerobic Gram-positive and Gram-negative organism isolates were included in the study.

All MALDI-TOF MS testing was performed in duplicate with the same swab spotted onto two spots on the target plate, one spot representing a “heavy” inoculum and the second spot representing a “light” inoculum. Acquisition and analysis of mass spectra was performed using the Microflex LT mass spectrometer (Bruker Daltonics; Fremont, CA, USA). For media studies, 84 Gram-negative bacteria were cultured on blood agar, chocolate agar, and MacConkey agar; 74 Gram-positive bacteria were cultured on blood agar, chocolate agar, and colistin nalidixic acid (CNA) agar. For temperature and stability studies, four Gram-negative bacteria and four Gram-positive bacteria were cultured onto blood agar. Results of MALDI-TOF MS were compared to routine methods performed in the microbiology laboratory. All discordant identifications were confirmed by additional biochemical or 16S rRNA sequencing.

In MALDI-TOF MS data interpretation, a score of equal to or greater than 2.0 is equivocal to reliable species-level identification, a score of 1.7–1.99 is considered reliable to the genus level and a score of less than 1.7 is considered unreliable for bacteria identification. Using the direct-smear method, 99.5% and 98.0% of aerobic Gram-negative and Gram-positive bacteria, respectively, were identified to the genus level. At a score of equal to or greater than 1.9, 97.6% Gram-negative organisms and 94.6% Gram-positive organisms were correctly identified to the species level by direct-smear method. Only 1.1% of isolates required further reflex to direct-plate extraction. The direct-smear method proved to be robust, as various growth temperatures, media, culture age, and different operators had no notable impact on the bacterial identification rate.

The authors concluded that the direct-smear method was accurate and effective in streamlining the workflow of Gram-positive and Gram-negative bacterial identification in our clinical laboratory. For simplicity, they recommend using the direct-smear method for the majority of specimens commonly found in the clinical laboratory and an optimized spectral score cutoff of equal to or greater than 1.9 for enhanced species-level identification rates. The study was first published on December 14, 2015, in the Journal of Clinical Laboratory Analysis.

Related Links:

Children's Hospital Los Angeles 
Keck School of Medicine 
Bruker Daltonics 



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Silver Member
Urine Test Strips
LabStrip U12 mALB/CREA
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: MG Tech adds STOMmics Stereo-seq spatial multi-omics technology to its potfolio (photo courtesy of STOmics)

MGI Tech Strengthens Sequencing Portfolio with Dual Acquisition

MGI Tech Co., Ltd. (Shenzhen, China) announced the acquisition of STOmics and CycloneSEQ on March 3, 2026, as part of its “SEQALL+GLI+Omics” strategy. According to the company, the combined portfolio spans... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.